Introduction
Primary biliary cirrhosis (PBC) is a chronic autoimmunologically mediated disease in which activated T lymphocytes attack and destroy epithelial cells by a nonsuppurative process in the bile duct where the autoimmuno-antigen mitochondrial enzyme PDC-E2 is abnormally distributed and overexpressed. 1 The destruction of small intrahepatic bile ducts leads to impaired bile secretion, progressive scarring, and the eventual development of cirrhosis and liver failure in PBC patients. 2, 3 Although auto-reactive immune responses against PDC-E2 have been well characterized in PBC, the lack of a transgenic mouse model so far has limited study of the mechanism of this disease induction and the development of novel approaches to therapy. 4 In an attempt to further explore the molecular events that orchestrate the tissue damage in mouse models, we cloned the murine cDNA sequence of this gene and analyzed the protein structure relationship as compared with the previously reported E2 component of human 5 and rat 6 alpha-ketoacid dehydrogenase complexes. Moreover, we report here, for the first time, the successful establishment of a bile duct cancer cell line that overexpresses PDC-E2, for the further study of PBC pathology.
Materials and methods

Cell culture
The mouse cell lines BML1-ME, NIH3T3, PA317, and PE501, and a human bile duct cancer cell line (KMBC) Background. The association between the dihydrolipoamide acetyltransferase component (E2) of pyruvate dehydrogenase complex (PDC) and primary biliary cirrhosis (PBC) is clinically established. However, the detailed pathological function of the PDC-E2 gene is as yet unclear. In order to study the gene function in knockout and transgenic mouse models, we cloned and characterized the mouse PDC-E2 (mPDC-E2) gene. Because the expression level of PDC-E2 was elevated in PBC bile duct cells, we tried to construct a bile duct carcinoma cell line that overexpressed PDC-E2 as a PBC cell model. Methods. The mPDC-E2 cDNA was obtained by the 3ЈRace method. We overexpressed this gene in KMBC cells, using a retrovirus vector. The transcript and translated protein of mPDC-E2 were detected by Northern blot and Western blot, respectively. Results. The deduced amino-acid sequence from the cloned cDNA indicated that the fully mature protein consisted of 557 amino-acid residues, with a calculated molecular mass of 59 kD. This mature protein was highly consistent with those of previously reported rat and human PDC-E2, which possessed three structurally identifiable regions: the lipoyl-bearing domain, the E3-binding site, and the catalytic domain. Mouse fibroblast NIH3T3 cells expressed one species of mPDC-E2 mRNA, 3.5 kb in length. We also successfully constructed a stable KMBC cell line overexpressing the PDC-E2. Conclusions. This is the first report of the mPDC-E2 sequence and is valuable for further investigation of PDC-E2 gene function in transgenic or knockout mouse models. The PDC-E2 overexpressing KMBC cell line can be used to study alterations in signal transduction or gene expression profiles in PBC bile duct.
were obtained from the University of Southern California School of Medicine. These cell lines were grown in Dulbecco's modified Eagle's medium (GIBCO-BRL, Rockville, MD, USA) supplemented with 10% (v/v) fetal bovine serum (GIBCO-BRL) (D-10), 100 mg/ml streptomycin sulfate (GIBCO-BRL), and 100 units/ml penicillin G (GIBCO-BRL). The cells were cultured at 37°C under an atmosphere of 5% CO 2 in air at 100% relative humidity.
Cloning of mPDC-E2
An mPDC-E2 cDNA fragment corresponding to the published human PDC-E2 sequence (Genbank access number, Y00978) 5 and rat PDC-E2 (Genbank access number, D10655) 6 were cloned using the 3Ј Race method. Total RNA was extracted from mouse hepatocellular carcinoma BML1-ME cells with TRIzol reagent (GIBCO-BRL), as described by the manufacturer. The RNA was reverse transcribed and amplified using a 3Ј Race reverse-transcription-polymerase chain reaction (RT-PCR) kit (Takara, Tokyo, Japan), with a forward primer (5Ј-CTGCTGCAGCTTTTGGGGTCGCCCG GCCGC-3Ј), which annealed to the Ϫ40 nucleotide (nt) to Ϫ10 nt sequences (the first codon of mature human PDC-E2 is ϩ1). The PCR product was subcloned into the pCR3.1-T vector (Invitrogen, Carlsbad, CA, USA) for sequencing. Analysis of five independent clones, each with the same 5Ј end, yielded a consensus sequence. Subsequently, NotI-ATG primer, which introduced the NotI cloning site and start codon ATG just before the cDNA sequence, corresponded to the first amino acid of mature mPDC-E2 (5Ј-CGCGGC CGCATGAGCCTCCCTCCGCATCAGAA-3Ј); and BamHI 3ЈPrimer (5Ј-GGATCCTTATAACAACA TAGTTATAGGCTTTTCAAAGG-3Ј), which introduced the BamHI site at the 3Ј end of mPDC-E2, were used to amplify the cDNA fragment in the pCR3.1-T cloning vector for transfer into a retrovirous pG1SvNa vector (Novartis, Duluth, GA, USA), 7 using the NotI and BamHI sites. The newly constructed vector was named pG1-mPDC-E2, and is illustrated in Fig. 1 .
Retrovirus production, infection, and selection of transduced cells
The retroviruses were prepared by the transinfection method. Briefly, 10 6 log phase PE501 packaging cells were plated into a 10-cm dish 24 h pretransfection. On day 2, these cells were transfected with retrovirus vectors, using a calcium phosphate transfection kit (5 primer-3 primer, Boulder, CO, USA) according to the manufacturer's recommendations. On day 3, the culture medium was replaced with 10 ml fresh D-10, and 2 ϫ 10 5 PA317 cells were seeded to another 10-cm dish. On day 4, 5 ml of the supernatant from the transfected PE501 cells was used to infect the PA317 cells in a 10-cm plate, at a final volume of 7 ml D-10, containing 8 µg/ml Polybrene (Sigma, St.Louis, MO, USA) and incubated overnight. On day 5, the PA317 cells were separated into new 10-cm dishes by 1 : 20 cell splitting and selected with D-10 medium, containing 0.6 mg/ml G418 (GIBCO-BRL) for 10 days. A total of ten G418-resistant monoclones were selected and separately cultured. The retrovirus titer of all the PA317 clones was estimated after infection of the NIH3T3 cells, as described previously. 8 For retrovirus infection, 2 ϫ 10 4 bile duct cancer KMBC cells were seeded in a 10-cm dish for 24 h before infection. On day 2, cell-free virus supernatant, at multiplicity of infection (MOI) ϭ 5, containing 8 µg/ml Polybrene, was added to the cell culture medium and incubated for 16 h at 37°C in a CO 2 incubator. After that, the culture medium containing the viruses was replaced with fresh D-10. The infection procedure was repeated again after 24-h culture, followed by 1 : 20 cell splitting and G418 (700 µg/ml) selection of transduced cells for 10 days. The G418-resistant monoclones were selected and separately cultured for further study.
Southern, Northern, and Western blotting analysis
For Southern blotting, the genomic DNA of each cell line, prepared using a Genomic DNA Kit (5 primer-3 primer) was subjected to electrophoresis in 0.8% agar- Fig. 1 . The integrated single-copy provirus of pG1-mPDC-E2 and its transcripts. LTR, Long terminal repeat; SV40, simian virus 40 promoter; Neo Resis, neomycin-resistant gene ose gel after digestion with restriction enzyme KpnI overnight, transferred onto a Hybond-XL nylon membrane (Amersham, Tokyo, Japan) and hybridized with a 32 P-labeled full-length mPDC-E2 probe, according to the standard method. 9 For Northern blotting, mRNAs were isolated from each cell line, using Oligotex ϪdT30 (Roche, Tokyo, Japan), as described by the manufacturer. The mRNAs were subjected to electrophoresis in 1.0% agarose gel containing 6.6% formaldehyde, with blotting on Hybond-XL in QuickHyb solution (Stratagene, La Jolla, CA, USA), under conditions described by the manufacturer, with the 32 P-labeled full-length mPDC-E2 probe and, subsequently, a beta-actin gene probe.
For Western blotting, each cell line in a 10-cm dish was harvested and washed with phosphate-buffered saline (PBS) twice. Cell pellets in tubes were suspended in 150 µl of lysis buffer, consisting of 20 mM Tris, 0.1% sodium dodecylsulfate (SDS), 1% Triton X-100, and 1% sodium deoxycholate. After sonication, the lysates were centrifuged at 10 000 g for 10 min. The supernatants were collected, and 30 µg of the protein samples was dissolved in 4 ϫ Laemmli buffer, heated for 5 min, and subjected to 12% SDS-polyacrylamide gel electrophoresis (PAGE). The electrophoresis, transmembrane, and blocking steps have been described elsewhere. 10 The hybridization was carried out using a rabbit-anti-mouse PDC-E2 monoclonal antibody prepared by a standard procedure, 11 using an ECL kit (Amersham) according to the manufacturer's instructions. Subsequently, the membrane was exposed to ECL film (Amersham). The antibody was stripped and re-hybridized with rabbit anti-beta-actin antibody (Wako, Osaka, Japan).
Results
Cloning of the mPDC-E2 gene and comparison with other mammalian species PDC-E2 protein
The deoxynucleotide sequence of mPDC-E2 and the deduced primary amino-acid sequence of mPDC-E2 are registered in the Genbank database under the accession number AV044265. All the amino-acid sequences determined chemically matched the predicted mPDC-E2 sequences. As shown in Fig. 2 , the mature mPDC-E2 consisted of 557 amino-acid residues, with a calculated molecular mass of 58 886 Daltons. Many previous studies, based on limited proteolytic digestion, have revealed that the E2 component was made up of three heterologous domains: a lipoyl-binding domain, a binding domain for E1 (pyruvate dehydrogenase) and/or E3 (dihydrolipoamide dehydrogenase), and an inner-core catalytic domain. 12 In this study, we identified these domains in mouse PDC-E2 according to the amino-acid alignment with other reported mammalian (human and rat) E2 complexes (Fig. 2) . The alignment results demonstrated that these E2 complexes shared completely identical lipoyl-binding domains and E3 nucleotide binding site motifs (G-X-G-X-X-G). The aligned amino acid of the inner-core catalytic domain exhibited 95.2% homology among the three species. The overall mPDC-E2 amino-acid sequence is considerably homologous to other mammalian species (88.8% to human and 96.1% to rat).
Expression of recombinant mature mPDC-E2 protein in mouse fibroblast cells
For the establishment of the PDC-E2 overexpressing cell line, a start codon ATG was introduced before the first amino acid, as described in "Materials and methods." The ten transduced PA317 monoclones were tested for retrovirus titers, and the highest one was 8 ϫ 10 4 CFU/ml. We selected five transduced KMBC cell monoclones. The expression of PDC-E2 in the individual clones was first determined by Northern blotting. The mRNA isolated from mouse NIH3T3 cells showed the presence of a unique mPDC-E2 hybridizing band at 3.5 kb, as displayed in Fig. 3 , lane A, which represented the mRNA for the internal expression of mPDC-E2. We detected that one transduced KMBC monoclone had an extra band at 4.8 kb (Fig. 3, lane C) , which is the expected size of retrovirus transcript from the long terminal repeat (LTR) (Fig. 1) . The overexpression of PDC-E2 in this monoclone was further confirmed by Western blotting (Fig. 4, lane B) , which illustrated that the KMBC monoclone increased the total PDC-E2 expression level to 2.5-fold, compared with pG1Sv Nainfected KMBC cells, while the actin level remained the same. The protein size of PDC-E2 in mouse fibroblasts and human KMBC cells is very similar, as shown by the Western blot result (Fig. 4, lanes B and C) . Seemingly, the NIH3T3 cells express a high basic level of mPDC-E2, as reflected in the strong positive immunostaining (data not shown). We subsequently conducted Southern blotting, as demonstrated in Fig. 5 , to assess the provirus integrity of the genome in this KMBC cell clone. The KpnI restriction enzyme only cut in the 5Ј and 3Ј LTRs (Fig. 1) . We detected one specific band, at 4.57 kb, in this clone, which was the expected size of the provirus insertion (Fig. 5, lane D) . The copy number of retrovirus insertion was one, which indicated that independent integration event had happened. A 15-kb size band was observed in both mock-transduced cells and the stable-expression clones (Fig. 5, lanes A and D) and was considered to be from genomic PDC-E2 after digestion. Taken together, these results show that we were able to construct a stable, integrated, 
Discussion
PDC-E2 is encoded by a nuclear gene and is synthesized as a precursor, with a leader sequence which is subsequently cleaved to generate a mature form in mitochondria. 13 In this study, we successfully cloned the cDNA sequence corresponding to mouse fully mature PDC-E2. However, we failed to clone the full-length mRNA of mPDC-E2 using the 5Ј Race RT-PCR method, which may indicate that the transcription starting site is relatively far from the head of our cloned sequence. The mature mPDC-E2 protein shared the same three domain structures as other reported mammalian PDC-E2: a lipoyl-binding domain, a binding domain for E1 and/ or E3, and an inner-core catalytic domain. Its aminoacid sequence was also highly homologous to that of other mammalian species-human 5 and rat. 6 Our Northern blot result showed that mouse fibroblast NIH3T3 cells only expressed one species of mPDC-E2 mRNA, at 3.5 kb in size, which is different from human PDC-E2, which presented three hybridization species, as shown in our Northern blot (Fig. 4, lane  B) and previously reported. 5 This may be due to the multiple polyadenylation signal in the 3Ј untranslated region of human PDC-E2, or to alternative splicing sites or multiple transcription initiation sites. 5 We further report here the establishment by employing retrovirus infection, of a stable PDC-E2 overexpressing bile duct cancer cell line (KMBC). The stable overexpressing cell line has an unimpaired one-copy provirus insertion, as shown in the Southern blot result. The mPDC-E2 protein has close electrophoretic mobility to that of human PDC-E2, as revealed in the Western blot result in Fig. 4 . Because the basic PDC-E2 expression level in NIH3T3 cells and other mouse cell lines is more abundant than that in human cell lines (data not shown), we con-structed a stable overexpressing human bile duct cancer cell line instead of a mouse cell line.
Clinically, increased PDC-E2 mRNA expression was observed in biliary epithelial cells in PBC patients, but not in these cells from patients with normal liver or with other biliary diseases, 1 which suggested that the increased immunoreactivity may occur because of the overexpression of PDC-E2, which caused gene expression profile or signal transduction changes either as an intact molecule or as a proteolytic fragment. Also, the overexpression of PDC-E2 implied a pathogenic association between PDC-E2 and ductal damage. Although the association between the presence of an autoreactive immunoresponse and PBC is well known, the mechanism of the breakdown of self-tolerance is unclear. Similarly, it is not clear how these auto-reactive responses are linked to the subsequent development of nonsuppurative destructive cholangitis. The study of the functions of other pathogenic genes has been significantly assisted by the availability of knockout and transgenic mouse models. Although the human 5 and rat 6 PDC-E2 gene has already been reported, the pathological function of PDC-E2 has not been clarified. The mPDC-E2 gene we cloned is valuable for the future investigation of gene function in the knockout mouse model, as well as for investigations of PBC in the transgenic model. The established PDC-E2 overexpressing bile duct cancer cell line was a cell model to study pathological changes in PBC bile duct. Our work may help to provide novel insights in the research of PBC pathogenesis, and may, ultimately, lead to new therapeutic targets.
